Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF RELATED PARTY NOTES PAYABLE (Details)

v3.22.4
SCHEDULE OF RELATED PARTY NOTES PAYABLE (Details) - USD ($)
 3 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Apr. 15, 2020
Defined Benefit Plan Disclosure [Line Items]      
Notes payable - related party $ 779,373 $ 779,373  
Ivar Siem [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Interest rate [1] 9.00%    
Date of maturity [1] Dec. 31, 2021    
Notes payable - related party [1] $ 278,435 278,435  
Mark M Allen [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Interest rate 9.00% [2]   9.00%
Date of maturity [2] Aug. 15, 2021    
Notes payable - related party [2] $ 55,000 55,000  
Mark M Allen One [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Interest rate [3] 12.00%    
Date of maturity [3] Jun. 30, 2020    
Notes payable - related party [3] $ 200,000 200,000  
Mark M Allen Two [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Interest rate [4] 9.00%    
Date of maturity [4] Jun. 30, 2021    
Notes payable - related party [4] $ 245,938 $ 245,938  
[1] On August 15, 2019, the Company entered into a loan agreement in the amount of $75,000 with Ivar Siem. The note bears interest at an interest rate of 12% per annum with a four (4) month maturity. On December 4, 2019, the Company entered into a loan agreement in the amount of $100,000 with Ivar Siem. The note bears interest at an interest rate of 12% per annum with a six (6) month maturity. At the maturity date, the note holder has the right to collect the principal plus interest or convert into 1,250,000 shares of common stock at $0.08 per share. In addition, if converted, the note holder will also receive 5,000,000 warrants at an exercise price of $0.10 per share, vesting immediately with a 36-month expiration period. On February 28, 2020, the Company entered into a $50,000 loan agreement with Ivar Siem. The note does not bear any interest (0% interest rate) and is due on demand. The note includes warrants to purchase 200,000 shares of common stock (the “Loan Warrants”), at an exercise price of $0.10 per share in Canadian dollars and expire on March 1, 2022. On January 1, 2021, the Company entered into an amended loan agreement in the amount of $278,435, which combined the three previous loans, along with accrued interest. The note bears an interest rate of 9% and matured on December 21, 2021.
[2] On April 15, 2020, the Company entered into an agreement, with Mark Allen, that included a funding clause where the Company borrowed $55,000 from Mr. Allen. The note bears interest at an interest rate of 9% per annum and matured on August 15, 2021.
[3] During 2019, the Company entered into a loan agreement in the amount of $200,000 with Mark Allen. The note bears interest at an interest rate of 12% per annum and matured on June 30, 2021. At the maturity date, the note holder has the right to collect the principal plus interest or convert into 2,500,000 shares of common stock at $0.08 per share. In addition, upon conversion, the note holder will also receive 10,000,000 warrants at an exercise price of $0.10 per share, vesting immediately with a 36-month expiration period.
[4] On January 3, 2020, the Company entered into a loan agreement in the amount of $100,000 with Mark Allen. The note bears interest at an interest rate of $10% per annum and matures on June 1, 2020, with warrants to purchase 400,000 shares of common stock (the “Loan Warrants”), at an exercise price of $0.10 per share in Canadian dollars and expire on January 3, 2023. The fair value of issued warrants were recorded as a debt discount of $31,946 and monthly amortization of $1,775. On February 14, 2020, the Company entered into a loan agreement in the amount of $125,000 with Mark Allen. The note bears interest at an interest rate of 10% per annum and matures on June 1, 2020, with warrants to purchase 750,000 shares of common stock (the “Loan Warrants”), at an exercise price of $0.10 per share in Canadian dollars and expire on February 14, 2022. The fair value of issued warrants were recorded as a debt discount of $38,249 and monthly amortization of $1,903. On January 1, 2021, the Company entered into an amended loan agreement in the amount of $245,938, which combined the two previous loans, along with accrued interest. The note bears an interest rate of 9% and matured on June 30, 2021.